Published in Br J Cancer on November 01, 1993
Malignant mesothelioma of the pleura: interobserver variability. J Clin Pathol (1995) 0.93
The need for specialist review of pathology in paediatric cancer. Br J Cancer (1997) 0.85
The measurement of observer agreement for categorical data. Biometrics (1977) 216.56
Statistical methods for assessing agreement between two methods of clinical measurement. Lancet (1986) 211.50
Misinterpretation and misuse of the kappa statistic. Am J Epidemiol (1987) 8.29
ASA physical status classifications: a study of consistency of ratings. Anesthesiology (1978) 7.23
A proposed index for measuring agreement in test-retest studies. J Chronic Dis (1966) 1.33
Prognostic factors for survival in hepatocellular carcinoma. Cancer Res (1988) 1.16
Lymphatic and blood vessel invasion in breast carcinoma: a useful prognostic indicator? Hum Pathol (1986) 1.11
Randomized comparison of doxorubicin and vindesine to doxorubicin for patients with metastatic soft-tissue sarcomas. Cancer (1990) 1.07
Interpretation of biopsies of "normal" urothelium in patients with superficial bladder cancer. MRC Superficial Bladder Cancer Sub Group. Br J Urol (1991) 0.99
Evaluation of pathology review of malignant lymphomas and Hodgkin's disease in cooperative clinical trials. The Eastern Cooperative Oncology Group experience. Cancer (1988) 0.95
The reproducibility of a quantitative grading system of bladder tumours. Histopathology (1985) 0.93
The pathology of non-Hodgkin's lymphoma of childhood: II. Reproducibility and relevance of the histologic classification of "undifferentiated" lymphomas (Burkitt's versus non-Burkitt's). Hum Pathol (1987) 0.85
How many raters? Toward the most reliable diagnostic consensus. Stat Med (1992) 0.81
End points and significance of reproducibility in pathology. Arch Pathol Lab Med (1989) 0.80
Using replicate observations in observer agreement studies with binary assessments. Biometrics (1991) 0.80
The design of observer agreement studies with binary assessments. Stat Med (1993) 0.80
Design and serendipity in establishing a large cohort with wide dietary intake distributions : the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol (2001) 11.17
Use of check lists in assessing the statistical content of medical studies. Br Med J (Clin Res Ed) (1986) 7.42
Breast cancer clusters in the northeast United States: a geographic analysis. Am J Epidemiol (1997) 5.73
Tables of the number of patients required in clinical trials using the logrank test. Stat Med (1983) 5.34
Allocation of patients to treatment groups in a controlled clinical study. Br J Cancer (1978) 5.25
The prevalence of glaucoma in Chinese residents of Singapore: a cross-sectional population survey of the Tanjong Pagar district. Arch Ophthalmol (2000) 4.59
Scoring system to improve cost effectiveness of open access endoscopy. Br Med J (Clin Res Ed) (1983) 4.09
On the use of Pocock and Simon's method for balancing treatment numbers over prognostic factors in the controlled clinical trial. Biometrics (1976) 3.82
Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial. Lancet (1999) 3.54
Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res (1978) 3.51
Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group. Int J Radiat Oncol Biol Phys (1996) 3.42
Deprivation and general practitioner workload. BMJ (1992) 3.13
Socioeconomic differentials in the uptake of medical care in Great Britain. J Epidemiol Community Health (1987) 2.99
Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst (1996) 2.98
Intention to treat--who should use ITT? Br J Cancer (1993) 2.74
A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer. Br J Surg (1985) 2.66
Implications of a new dietary measurement error model for estimation of relative risk: application to four calibration studies. Am J Epidemiol (1999) 2.40
Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup. Lancet (1997) 2.33
Empirical evidence of correlated biases in dietary assessment instruments and its implications. Am J Epidemiol (2001) 2.33
Health risks associated with bathing in sea water. BMJ (1991) 2.24
Injuries sustained on "bouncy castles". BMJ (1992) 2.20
Detection of gonioscopically occludable angles and primary angle closure glaucoma by estimation of limbal chamber depth in Asians: modified grading scheme. Br J Ophthalmol (2000) 2.11
Randomised consent designs in cancer clinical trials. Eur J Cancer (1995) 2.07
Competing risks analysis of patients with osteosarcoma: a comparison of four different approaches. Stat Med (2001) 2.04
Doctors on tribunals. A confusion of roles. Br J Psychiatry (2000) 2.02
On the evaluation of the clinical effects of acupuncture. Pain (1983) 2.01
Prospective testing of a scoring system designed to improve case selection for upper gastrointestinal investigation. Gastroenterology (1986) 1.98
Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Medical Research Council Lung Cancer Working Party. Clin Oncol (R Coll Radiol) (1996) 1.93
Histological grade and other prognostic factors in relation to survival of patients with breast cancer. Br J Cancer (1979) 1.92
Is the statistical assessment of papers submitted to the "British Medical Journal" effective? Br Med J (Clin Res Ed) (1983) 1.92
The CHART trials: Bayesian design and monitoring in practice. CHART Steering Committee. Stat Med (1994) 1.90
Potential impact of genetic testing on cancer prevention trials, using breast cancer as an example. J Natl Cancer Inst (1995) 1.84
A predictive approach to selecting the size of a clinical trial, based on subjective clinical opinion. Stat Med (1986) 1.82
The autopsy: a useful tool or an old relic? J Pathol (1988) 1.81
Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet (1987) 1.79
Anterior chamber depth measurement as a screening tool for primary angle-closure glaucoma in an East Asian population. Arch Ophthalmol (2000) 1.76
Incomplete quality of life data in randomized trials: missing items. Stat Med (1998) 1.71
Accuracy of clinical estimates of intraocular pressure in Chinese eyes. Ophthalmology (2000) 1.63
The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up. J Urol (1996) 1.63
Interpreting precursor studies: what polyp trials tell us about large-bowel cancer. J Natl Cancer Inst (1994) 1.61
Guidelines for reporting results of quality of life assessments in clinical trials. Qual Life Res (1996) 1.58
Myelodysplastic syndromes: a scoring system with prognostic significance. Br J Haematol (1985) 1.57
Can energy adjustment separate the effects of energy from those of specific macronutrients? Am J Epidemiol (1994) 1.56
Seasonality of suicide in Singapore: data from the equator. Psychol Med (2001) 1.54
Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer. The basis for a prognostic index. Cancer (1991) 1.49
Response to N7 induction chemotherapy in children more than one year of age diagnosed with metastatic neuroblastoma treated in UKCCSG centers. Pediatr Blood Cancer (2007) 1.49
The use of a Kolmogorov--Smirnov type statistic in testing hypotheses about seasonal variation. J Epidemiol Community Health (1979) 1.49
A community-based study of scaling assumptions and construct validity of the English (UK) and Chinese (HK) SF-36 in Singapore. Qual Life Res (2001) 1.48
Trends in induced abortion in England and Wales. J Epidemiol Community Health (1983) 1.46
Life after radiotherapy: the psychological and social effects experienced by women treated for advanced stages of cervical cancer. Gynecol Oncol (2000) 1.45
Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison. Br J Cancer (2005) 1.42
Coping with extra Poisson variability in the analysis of factors influencing vaginal ring expulsions. Stat Med (1991) 1.42
Bayesian monitoring of phase II trials in cancer chemoprevention. J Clin Epidemiol (1999) 1.41
A stratified Wilcoxon-type test for trend. Stat Med (1990) 1.40
The future of prognostic factors in outcome prediction for patients with cancer. Cancer (1992) 1.39
Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party). Br Med J (Clin Res Ed) (1988) 1.39
Randomised trial of compliance with screening for colorectal cancer. Br Med J (Clin Res Ed) (1986) 1.38
Incomplete quality of life data in randomized trials: missing forms. Stat Med (1998) 1.34
Socioeconomic status, systolic blood pressure and intraocular pressure: the Tanjong Pagar Study. Br J Ophthalmol (2006) 1.34
Randomized trials with quality of life endpoints: are doctors' ratings of patients' physical symptoms interchangeable with patients' self-ratings? Qual Life Res (1997) 1.33
Stopping rules for clinical trials incorporating clinical opinion. Biometrics (1984) 1.33
Quality of life assessment in clinical trials--guidelines and a checklist for protocol writers: the U.K. Medical Research Council experience. MRC Cancer Trials Office. Eur J Cancer (1997) 1.32
Effect of starvation on the tissue composition of the small intestine in the rat. Am J Physiol (1968) 1.31
Variations in the level of reporting by hospitals to a regional cancer registry. Br J Cancer (1978) 1.29
Randomised comparative studies in the treatment of cancer in the United Kingdom: room for improvement? Lancet (1979) 1.29
Acupuncture compared with placebo in post-herpetic pain. Pain (1983) 1.29
Young age is not a poor prognostic marker in colorectal cancer. Br J Surg (1998) 1.28
Randomized, placebo-controlled, double-blind study of low-dose oral interferon-alpha in HIV-1 antibody positive patients. J Acquir Immune Defic Syndr (1992) 1.27
An assay for dopamine-beta-hydroxylase activity in tissues and serum. Experientia (1971) 1.26
Approaches to the analysis of quality of life data: experiences gained from a medical research council lung cancer working party palliative chemotherapy trial. Qual Life Res (1994) 1.26
Unexpected sudden infant deaths in Gosport--some comparisons between service and civilian families. J R Nav Med Serv (1983) 1.23
Relationship between thermal dose and outcome in thermoradiotherapy treatments for superficial recurrences of breast cancer: data from a phase III trial. Int J Radiat Oncol Biol Phys (1997) 1.22
The role of post-operative radiotherapy in non-small-cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 disease. Medical Research Council Lung Cancer Working Party. Br J Cancer (1996) 1.20
Treatment-related deaths in small cell lung cancer trials: can patients at risk be identified? Medical Research Council Lung Cancer Working Party. Lung Cancer (1994) 1.20
Multivariate analysis of prognostic factors for operable rectal cancer. Lancet (1984) 1.18
Defining "occludable" angles in population surveys: drainage angle width, peripheral anterior synechiae, and glaucomatous optic neuropathy in east Asian people. Br J Ophthalmol (2004) 1.17
Risk factors for nuclear, cortical and posterior subcapsular cataracts in the Chinese population of Singapore: the Tanjong Pagar Survey. Br J Ophthalmol (2003) 1.15
Sample size: how many patients are necessary? Br J Cancer (1995) 1.15
The polyp prevention trial I: rationale, design, recruitment, and baseline participant characteristics. Cancer Epidemiol Biomarkers Prev (1996) 1.15
The analysis of vaginal bleeding patterns induced by fertility regulating methods. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction. Contraception (1986) 1.15
Monitoring clinical trials: conditional or predictive power? Control Clin Trials (1986) 1.14
Sudden infant death in Southampton and an evaluation of the Sheffield scoring system. J Epidemiol Community Health (1982) 1.14
Interplay between design and analysis for behavioral intervention trials with community as the unit of randomization. Am J Epidemiol (1995) 1.13
A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology. J Med Genet (2003) 1.13
Inequalities in health: changes in RHAs in the past decade. Br Med J (Clin Res Ed) (1987) 1.13
Effect of different types and amounts of fat on the development of mammary tumors in rodents: a review. Cancer Res (1997) 1.11
Seasonal variations in the presentation and growth of thyroid cancer. Br J Cancer (1999) 1.11
The effects of acupuncture versus placebo in the treatment of headache. Pain (1985) 1.10
An overview of published results from randomized studies of nitrosoureas in primary high grade malignant glioma. Br J Cancer (1987) 1.10
System delay in breast cancer in whites and blacks. Am J Epidemiol (1995) 1.09
Quality of life of Danish women: population-based norms of the EORTC QLQ-C30. Qual Life Res (1997) 1.08
Association between psychological symptoms in adults and growth in early life: longitudinal follow up study. BMJ (2002) 1.08
Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type. Ann Oncol (2002) 1.08
Obstructive sleep apnea syndrome in obese Singapore children. Pediatr Pulmonol (2000) 1.07
Applying Bayesian ideas in drug development and clinical trials. Stat Med (1993) 1.07
Validation of intermediate end points in cancer research. J Natl Cancer Inst (1990) 1.07
Serum dopamine-beta-hydroxylase activity in neuroblastoma. N Engl J Med (1972) 1.05